Industry committee  I can speak to that, because I think it's a legal question more than a medical one. There are a number of other jurisdictions that have adopted a version of CAMR. They've put in something in some form, in regulation, legislation, state directive, what have you, that implements th

Industry committee  Yes.

Industry committee  The European Union has adopted a regulation that is applicable throughout all the EU member states. The Netherlands is not a G-8 country, but it is a high-income country. Switzerland was drafting one. And then the others would be countries like India, Korea, and so on. They're no

Industry committee  No.

Industry committee  I just wanted to add one thing. We must remember that the drugs from suppliers in India are generic drugs and these are the drugs we are currently using to treat patients with HIV. For the most part, they are first-line antiretroviral drugs. That is why we now have 5.2 million pe

Industry committee  That is going to change, isn't it?

Industry committee  Yes, the second question, yes. There is, I think, a somewhat simplistic mischaracterization of what the bill would do on this question of ensuring the safety and quality of medicines. The first thing I should say is, as an advocate for treatment for people, I want people to get

Industry committee  In 2003-04, when the discussions were under way about drafting what is now CAMR, this issue did come up a few times in discussion. There was very little appetite to do that, it appeared, on the part of the federal government departments that were involved at the time, and I suspe

Industry committee  On the first question, about compliance with WTO obligations, the proposals that are in Bill C-393 have been drafted with the expertise of people who know what the WTO law says, and very much taking that into consideration. There is extensive discussion in our brief of this ver

Industry committee  The most recent figure I've seen--and it may be a year or so out of date--is approximately 8,000 deaths a day from AIDS.

Industry committee  Thank you. Perhaps I could save the fourth part of my remarks--the question of what Bill C-393does not do--for the question-and-answer session, because I expect that I will get a number of questions about what it is claimed that Bill C-393 will do, and I would be happy to correc

Industry committee  Thank you, Mr. Chair, and thank you to the members of the committee for the opportunity to appear before you today. Thank you as well to the committee for actually studying this bill, because I know that was something that has been in some question. I want to draw your attention

Justice committee  Yes. I would like to say two things. First, of course, we have the historical example of alcohol prohibition. We repealed prohibition. We regulate alcohol. It's worked a lot better. The second thing I'd like to say is that we have lots of evidence to say that even if you take

Justice committee  Thank you. We've heard a number of times that the concern that should be driving mandatory minimum sentences is that judges aren't sentencing harshly enough. Whether or not that is true is quite debatable, and we've heard some debate about it. Even if it were true, it doesn't l

Justice committee  I think I was asked to respond as well.